期刊文献+

FOX03a在三氧化二砷影响大肠癌细胞β—catenin表达中的作用 被引量:1

Effects of FOXO3a on the expression of β- catenin in colorectal cancer cells exposed to As2O3
下载PDF
导出
摘要 目的探究三氧化二砷(As2O3)对侵袭相关因子β—catenin表达的影响是否与FOXO3a有关。方法采用脂质体转染siRNA以及LY294002药物改变大肠癌SW620细胞中FOXO3a的表达,Western blot检测FOXO3a、β—catenin蛋白表达水平,RT—PCR检测FOXO3a、β—catenin mRNA表达水平。结果As2O3增加SW620细胞中FOXO3a蛋白及mRNA的表达,同时降低β—catenin蛋白及mRNA表达(P〈0.05)。FOXO3a基因干扰后,β—catenin蛋白及mRNA的表达上调(P〈0.05)。LY294002药物处理后,β—catenin表达下调(P〈0.05)。结论As2O3对人大肠癌SW620细胞中β—catenin表达的抑制作用可能与其增强FOXO3a的活性有关。 Objective To investigate whether FOXO3a is involved in the changed expression of β - catenin in colorectal cancer SW620 ceils after exposure to arsenic trioxide ( As2O3 ). Methods The expression of FOXO3a was changed by FOXO3a specific siRNA and LY294002. Then, the protein and mRNA expressions of FOXO3a and β- catenin in eoloreetal cancer SW620 cells were detected by western blot and RT -PCR, respectively. Results As2O3 can stimulate the protein and mRNA expressions of FOXO3a in SW620 cells, while reducing the expression of β - catenin at protein and mRNA levels (P 〈 0.05 ). After FOXO3a gene silencing, the protein and mRNA expressions of β -catenin were obviously enhanced ( P 〈 0.05 ). But LY294002 treatment could remarkably inhibit the expression of β - catenin at protein and mRNA levels. Conclusion The inhibitory effects of As2O3 on β - eatenin in eolorectal cancer SW620 cells may be associate with its ability to enhance the activity of FOXO3a.
出处 《徐州医学院学报》 CAS 2014年第4期258-261,共4页 Acta Academiae Medicinae Xuzhou
基金 江苏省高校自然科学基金(12KJD320006,07KJD310217) 徐州市科技局项目(XF11C1002011)
关键词 三氧化二砷 大肠癌 FOXO3A β—catenin arsenic trioxide colorectal cancer FOXO3a β- catenin
  • 相关文献

参考文献2

二级参考文献20

  • 1王南瑶,李苏宜,赵伟,秦叔逵,刘琳,陈慧英.华蟾素联合三氧化二砷抑制鸡胚尿囊膜血管生成的实验研究[J].临床肿瘤学杂志,2006,11(7):494-496. 被引量:28
  • 2郝春蕾.华蟾素治疗恶性肿瘤及其不良反应[J].中国药师,2007,10(7):704-706. 被引量:8
  • 3Chen Z, Zhao WL, Shen ZX, et al. Arsenic trioxide and acute promyelocytic leukemia: clinical and biological [ J ]. Curr Top Microbiol Immunol, 2007, 313 : 129 - 144.
  • 4Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract [J]. Cancer Res, 1993,53(19) : 4727 -4735.
  • 5Eric Raymond, Sandrine F. Epidermal growth factor receptor tyrosin kinase as a target for anticanter[ J]. Drugs, 2000,60 (1 suppl) :15 -23.
  • 6BURGERING B M,KOPS G J.Cell cycle and death control:longlive Forkheads[J].Trends Biochem Sci,2002,27(7):352-360.
  • 7GROSS D N,WAN M,BIRNBAUM M J.The role of FOXO inthe regulation of metabolism[J].Curr Diab Rep,2009,9(3):208-214.
  • 8NAKA K,HOSHII T,MURAGUCHI T,et al.TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronicmyeloid leukaemia[J].Nature,2010,463(7281):676-680.
  • 9HUANG E J,REICHARDT L F.Trk receptors:roles in neuronalsignal transduction[J].Annu Rev Biochem,2003,72:609-642.
  • 10SALINAS M,DIAZ R,ABRAHAM N G,et al.Nerve growth fac-tor protects against 6-hydroxydopamine-induced oxidative stressby increasing expression of heme oxygenase-1 in a phosphatidyli-nositol 3-kinase-dependent manner[J].J Biol Chem,2003,278(16):13898-13904.

共引文献36

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部